Lifecore Biomedical to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR), a contract development and manufacturing organization (CDMO), has announced its participation in three upcoming investor conferences in September 2025.

The company will participate in the Morgan Stanley Global Healthcare Conference (Sept 8-10) featuring a fireside chat, the Barrington Research Virtual Fall Investment Conference (Sept 16), and the Jefferies CDMO Summit (Sept 17). The Morgan Stanley fireside chat will be webcast live and available for replay on Lifecore's investor website.

CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore’s participation are as follows:

• Morgan Stanley 23^rd Annual Global Healthcare Conference
  Details: Lifecore management will participate in a fireside chat and in investor meetings
  Conference Dates: September 8-10, 2025
  Fireside Chat Time: 4:50 – 5:25 p.m. Eastern on Tuesday, September 9, 2025, webcast available
  Location: New York, NY

• Barrington Research Virtual Fall Investment Conference
  Details: Lifecore management will participate in investor meetings
  Conference Date: September 16, 2025
  Location: Virtual

• Jefferies CDMO Summit 2025
  Details: Lifecore management will participate in investor meetings
  Conference Date: September 17, 2025
  Location: London, UK

A live webcast of the Morgan Stanley fireside chat may be accessed via a link on Lifecore’s investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, a replay of the webcast will be available on the Lifecore website following the conference.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com 

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com 

Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
ryan.lake@lifecore.com

FAQ

When is Lifecore Biomedical's (LFCR) fireside chat at the Morgan Stanley Healthcare Conference 2025?

Lifecore's fireside chat is scheduled for Tuesday, September 9, 2025, from 4:50 to 5:25 p.m. Eastern at the Morgan Stanley Global Healthcare Conference in New York.

How can investors access Lifecore Biomedical's Morgan Stanley conference presentation?

Investors can access the live webcast and replay of the fireside chat through Lifecore's investor website at ir.lifecore.com/events-presentations.

Which investor conferences will Lifecore Biomedical (LFCR) attend in September 2025?

Lifecore will attend three conferences: the Morgan Stanley Global Healthcare Conference (Sept 8-10), Barrington Research Virtual Fall Investment Conference (Sept 16), and Jefferies CDMO Summit (Sept 17).

Where will the Lifecore Biomedical investor conferences be held?

The Morgan Stanley conference will be held in New York, the Barrington Research conference will be virtual, and the Jefferies CDMO Summit will take place in London, UK.